The largest database of trusted experimental protocols

7 protocols using anti cd63

1

Exosome Isolation from Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sera from healthy controls, patients with primary breast cancer, and metastatic breast cancer to the bones were collected. For isolation from cell lines, after culturing was conducted wild-type (negative control), shCBFB-transfected, or CBFB-OE-transfected breast cancer cell lines in serum-free medium for 48 h, the culture media were collected. Exosomes were isolated from collected serum and culture media as previously described [18 (link)]. Briefly, after repeated centrifugation and ultracentrifugation (500 × g for 10 min, 1200 × g for 20 min, and 10,000 × g for 30 min), filtration with 0.22 μm pore syringes, and a spin at 100,000 × g for 60 min, the cell pellet was collected, washed in 1× PBS three times, and ultracentrifuged at 100,000 × g for 60 min; subsequently, the exosomes were harvested from the supernatant. The harvested exosomes were used for further analysis. Western blot analysis with anti-CD63 (Cat No. H5C6, Novus Biologicals, CO, USA) and anti-CD9 (Cat No. 5G6, Novus Biologicals) antibodies was used to confirm the presence of exosomes.
+ Open protocol
+ Expand
2

Western Blot Analysis of Extracellular Vesicles

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Western blotting, 20 µg or 5 µg of total protein were used for cell lysates and EV protein respectively. Samples were diluted in Laemmli buffer and incubated at 98°C for 5 min. Protein samples were resolved using Tris/Glycine/SDS pre‐cast polyacrylamide gels and a BioRad Western blot system running at 200 V for 32 min. Protein was transferred from polyacrylamide gel to polyvinylidene fluoride membranes via wet transfer for 90 min at 70 V. Membranes were then blocked in 5% non‐fat milk in TBS‐Tween (0.1% Tween 20) for 1 h at RT. Membranes were incubated with primary antibodies at dilutions recommended by the manufacturer (anti‐CD9, Cell Signaling Technology, Cat#: D8O1A, 1:500 dilution; anti‐CD63, Novus Biologicals, Cat#: NB100‐77913, 1:250 dilution; anti‐flotillin‐1, BD Biosciences, Cat#: 610820, 1:500 dilution; anti‐GM130, BD Biosciences, Cat# 610822, 1:500 dilution) in blocking buffer for either 3 h at RT or overnight at 4°C, washed three times in TBS‐Tween for 10 min, and incubated with HRP‐conjugated secondary antibodies in blocking buffer for 1 h at RT. Membranes were then washed three times in TBS‐Tween for 10 min and developed in ECL detection reagents (GE Healthcare).
+ Open protocol
+ Expand
3

Antibody Panel for Extracellular Vesicle Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies (Abs) were used in the experiments of this study: anti‐CD9 (BioLegend, Cat# 312102; San Diego, CA, USA), anti‐CD63 (Novus Biologicals, Cat# NBP2‐42225; Centennial, CO, USA), anti‐CD81 (BioLegend, Cat# 349502), anti‐IGF1R (ganitumab, a kind gift from Dr. J.C. Williams), anti‐cytochrome C (BD Biosciences, Cat# 556432; Franklin Lakes, NJ, USA), anti‐syntenin (Abcam, Cat# ab19903; Waltham, MA, USA) and anti‐ApoA1 (Abcam, Cat# ab52945) Abs, as well as goat anti‐rabbit (anti‐rabbit IgG; Invitrogen, Cat# A16112; Waltham, MA, USA), IRDye 800CW goat anti‐mouse (Li‐Cor Biotechnology, Cat# 926–32210; Lincoln, NE, USA) and IRDye 680RD goat anti‐rabbit (Li‐Cor Biotechnology, Cat# 926–68071) secondary Abs. For ExoView experiments, fluorescently labelled anti‐CD9‐CF488A, anti‐CD63‐CF647 and anti‐CD81‐CF555 Abs from the manufacturer's kit were used (details below). Human lactadherin (MFG‐E8), aa Leu24‐Cys387 (contains both C1 and C2 domains) was purchased from Novus Biologicals (Cat# 2767‐MF‐050).
+ Open protocol
+ Expand
4

Microvesicle and Exosome Profiling in Urine

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microvesicle and exosome fractions from 16 ml urine samples were separated by SDS-PAGE (8–16% acrylamide gradient) and then transferred to a nitrocellulose membrane. The membrane was blocked with 1% bovine serum albumin (BSA) in PBS plus 0.1% Tween-20 (PBST), rinsed in PBST, and labeled with one of the following primary human antibodies diluted in 1% BSA in PBST: anti-CD63 (Novus Biological, Littleton, CA, USA), anti-CD81 (Novus Biological, Littleton, CA, USA), or anti-CD45 (LifeSpan BioSciences, Seattle, WA, USA) [41 (link)]. After rinsing again in PBST, the membrane was incubated with horseradish peroxidase (HRP)-conjugated anti-mouse secondary antibodies (Novus Biological, Littleton, CA, USA). Chemiluminescence was detected and quantified using the ChemiDoc Touch Imaging System and Image Lab software (Bio-Rad, Hercules, CA, USA).
+ Open protocol
+ Expand
5

Subcellular Localization of Signaling Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression and subcellular localization of EGFR, phosphorylated ERK (p42/44) and, phosphorylated p38 was tested by indirect immunofluorescence staining and confocal microscopy. Staining was done on FFPE tissue sections. The antibodies used were anti-EGFR (Cell Signaling, #42675), anti-phospho-ERK (Cell Signaling, RRID-AB-331775), anti-p38 (Cell Signaling, RRID-AB2139682), anti-ALIX (NOVUS, RRID-AB-960843) and, anti-CD63 (NOVUS, RRID-AB-108402). Primary antibodies were diluted according to manufacturers’ recommendations and incubated at 4°C overnight. Secondary antibodies labeled with Alexa Fluor 555 and Alexa Fluor 488 (Invitrogen), were incubated for one hour at room temperature. The nonspecific background was removed using blocking solution (DAKO). DAPI was used to counter stain the nuclei. Immuno-stained sections were visualized by laser scanning confocal microscope (LSM 700, Zeiss, Germany). Colocalization coefficients were calculated by Zen software (Zeiss, version 14.0.0.201, Germany) based on the co-occurrence of the red and green signals and their relative intensities. Colocalization coefficient of >0.5 was considered as positive co-expression.
+ Open protocol
+ Expand
6

Western Blotting of Exosomal Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed as described previously (Hosoi et al., 2014 (link)) albeit with some modifications. Briefly, the cells were washed and lysed for 20 min with RIPA buffer containing 25 mM Tris HCl (pH 7.6), 150 mM NaCl, 1% NP-40, 0.1% SDS, 1% sodium deoxycholate, 1 mM Na3VO4, 10 mM NaF, 10 μg/mL aprotinin, 10 μg/mL leupeptin, and 1 mM phenylmethylsulfonyl fluoride (PMSF). The lysates were incubated on ice for 20 min. Then, the samples were sonicated for 4 min and suspended for 30 min at 4°C. After additional sonication for 4 min, the samples were centrifuged at 14,000 rpm for 5 min at 4°C, and the supernatants were collected. The samples were then boiled in SDS sample buffer for 3 min, fractionated with SDS-PAGE, and transferred to nitrocellulose membranes. These membranes were then incubated with anti-CD63 (Novus; 1:1000), anti-calnexin (Enzo; 1:1000), anti-CD81 (Cell signaling; 1:1000), and anti-IRE1α (Cell signaling; 1:1000) antibodies, followed by an anti-horseradish peroxidase-linked antibody. Peroxidase binding was detected using chemiluminescence with an enhanced chemiluminescence system.
+ Open protocol
+ Expand
7

Quantitative Analysis of CD63 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD63 expression was quantitatively analyzed using Western blotting. Purified exosomes were mixed with 5% sodium dodecyl sulfate (SDS) sample buffer (Tech & Innovation, Gangwon, Republic of Korea), and sliced tissues were lysed and homogenized in radio-immunoprecipitation assay buffer (Tech & Innovation, Republic of Korea) containing protease inhibitors. The protein concentrations of the separated solutions were measured using the Bradford assay (Bio-Rad, Hercules, CA, USA). The samples were heated for 10 min at 97 °C. Next, 15 µg of protein from each sample was subjected to SDS-polyacrylamide gel electrophoresis (PAGE) (12%) and transferred to polyvinylidene difluoride (PVDF) membranes (Bio-Rad) for 90 min. Each membrane was blocked with 5% skim milk (BD Life Sciences, Franklin Lakes, NJ, USA) in TBST buffer (25 mM Tris, 190 mM NaCl, and 0.05% Tween 20, pH 7.5) for 1 h at room temperature, followed by incubation with primary antibodies (anti-CD63, 1:300; Novus Biologicals, Centennial, CO, USA) at 4 °C overnight. After five 20 min washes with TBST, each membrane was washed three times in Tween-20 and incubated with goat anti-mouse IgG for 2 h. Bands were visualized using an enhanced chemiluminescence system; the intensity of the blots was quantified with Image J 1.44 software (https://imagej.nih.gov/ij/plugins/index.html) [43 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!